Literature DB >> 4969117

Live, attenuated rubella-virus vaccine.

M R Hilleman, E B Buynak, R E Weibel, J Stokes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4969117     DOI： 10.1056/NEJM196808082790607

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  A comparative field evaluation of three live, attenuated rubella virus vaccines.

Authors:  A F Kehrer; P Isacson
Journal:  Am J Public Health       Date:  1971-01       Impact factor: 9.308

Review 2.  T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Authors:  Anne Monette; Andrew J Mouland
Journal:  Int Rev Cell Mol Biol       Date:  2018-10-24       Impact factor: 6.813

3.  Recombinant rubella vectors elicit SIV Gag-specific T cell responses with cytotoxic potential in rhesus macaques.

Authors:  Margherita Rosati; Candido Alicea; Viraj Kulkarni; Konstantin Virnik; Max Hockenbury; Niranjan Y Sardesai; George N Pavlakis; Antonio Valentin; Ira Berkower; Barbara K Felber
Journal:  Vaccine       Date:  2015-03-21       Impact factor: 3.641

Review 4.  A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health.

Authors:  Roberto Biselli; Roberto Nisini; Florigio Lista; Alberto Autore; Marco Lastilla; Giuseppe De Lorenzo; Mario Stefano Peragallo; Tommaso Stroffolini; Raffaele D'Amelio
Journal:  Biomedicines       Date:  2022-08-22

5.  Live attenuated rubella vectors expressing SIV and HIV vaccine antigens replicate and elicit durable immune responses in rhesus macaques.

Authors:  Konstantin Virnik; Max Hockenbury; Yisheng Ni; Joel Beren; George N Pavlakis; Barbara K Felber; Ira Berkower
Journal:  Retrovirology       Date:  2013-09-16       Impact factor: 4.602
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.